当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
Hepatology ( IF 12.9 ) Pub Date : 2022-09-02 , DOI: 10.1002/hep.32769
Bolni Marius Nagalo 1, 2, 3 , Yumei Zhou 1, 4 , Emilien J Loeuillard 5 , Chelsae Dumbauld 1, 4 , Oumar Barro 1, 4 , Natalie M Elliott 1, 4 , Alexander T Baker 1, 4 , Mansi Arora 1, 4 , James M Bogenberger 1, 4 , Nathalie Meurice 1, 4 , Joachim Petit 1, 4 , Pedro Luiz Serrano Uson 1, 4, 6 , Faaiq Aslam 1, 4 , Elizabeth Raupach 1, 4 , Musa Gabere 1, 4 , Alexei Basnakian 2, 7 , Camila C Simoes 2, 3 , Martin J Cannon 3, 8 , Steven R Post 2, 3 , Kenneth Buetow 9 , Jean Christopher Chamcheu 10 , Michael T Barrett 1, 4 , Dan G Duda 11 , Bertram Jacobs 12 , Richard Vile 1, 13 , Michael A Barry 1, 13, 14 , Lewis R Roberts 5 , Sumera Ilyas 5 , Mitesh J Borad 1, 4, 13, 15
Affiliation  

Morreton virus (MORV) is an oncolytic Vesiculovirus, genetically distinct from vesicular stomatitis virus (VSV).

中文翻译:


莫雷顿病毒作为肝癌溶瘤病毒治疗平台的特征



莫雷顿病毒 (MORV) 是一种溶瘤水泡病毒,在基因上与水泡性口炎病毒 (VSV) 不同。
更新日期:2022-09-02
down
wechat
bug